We Believe People Create All Value
We reinvest it in our planet.
We reinvest it in our planet.
Earth’s biodiversity inspires all of us at Enveda. That’s why our pledge to equitably share the benefits of biological resource use is an ethical foundation of our company. We are deeply committed to compliance with the Convention on Biological Diversity and the Nagoya Protocol, and to the rights of countries, local communities, and indigenous peoples to their plant resources.
Together with our partners, we are dedicated to applying our research and development capabilities in a sustainable manner. Please contact us to learn more about how we develop solutions to today’s biggest health care challenges while ensuring the conservation, sustainable use, and the just sharing of the benefits from Earth’s biodiversity.
Medicines deliver not just care, but hope. Millions of patient—maybe you’re one–battle on bravely, waiting for a treatment, for a chance at restored health and a normal, fulfilled life. At Enveda, we rise every morning to ensure that soon, patients and their families–all of us–will always have hope.
At Enveda, our drug discovery team of biologists, chemists, bioinformaticians, and data scientists spans three continents and six time zones. We’re all united by a common vision: decoding the chemical basis of life on planet Earth. We know that as we continue to progress towards our vision, we will unlock unprecedented impact across human and planetary health.
Associate Vice President, Corporate Development
Soum brings nearly 10 years of experience across investment banking and strategy consulting. He worked at Goldman Sachs, where he advised management teams of health care companies on a range of strategic financial matters and executed financings and M&A transactions. At Enveda, he is leading corporate development. Outside of work, Soum is usually found hiking, camping, watching too many movies and TV shows, and cheering on Golden State.
Vice President, Legal, Intellectual Property
Jason has extensive experience counseling early-stage, late-stage, and big pharma companies on technology law including intellectual property, and biotech and health tech business support. Jason is leading the development, management, and commercialization of Enveda’s intellectual property. During his free time, he enjoys cooking, playing squash, and spending time with his family.
Chief Business Officer
Vanitha has over two decades of experience in pharma, biotech, and the FDA where she held leadership roles in regulatory affairs, clinical research, strategy and business development. As Chief Business Officer, she is responsible for driving Enveda’s growth by shaping and executing the company’s business development and portfolio strategy. Vanitha has a passion for mentoring and developing women, minorities and immigrants in early career and leadership roles.
Vice President, Software Engineering
Valerie Pearce brings more than 25 years of software engineering experience to Enveda. With a background spanning health care, education, manufacturing, and big tech, Valerie has come to value people, empirical process control, and generative cultures.
Vice President, Machine Learning
Prior to joining Enveda, Tom led machine learning projects at a major technology company spanning question answering, machine translation, and web search. His academic training is in physics, biology, and computation. At Enveda, Tom leads our efforts in machine learning. In his spare time, Tom spends his time with his small children, and in the outdoors.
Chief Science Officer
Sotirios has a broad background in academic teaching and research, including major thought-leading academic medical centers, and in leadership positions at global pharmaceutical companies including Eli Lilly and AstraZeneca. As Chief Science Officer of Enveda, Sotirios focuses on the delivery of clinical and IND candidates in a range of diverse disease indications. Outside of work, Sotirios takes care of his son, who has autism; reads history; and learns about finance.
Chief People Officer
Robert believes people create all value. Creating fantastic candidate and employee experiences makes Enveda a place to do amazing work. Outside of Enveda, Robert enjoys reading, family time, and coaching soccer.
Vice President, Non-Clinical Development
Peter is a seasoned pharmaceutical professional with experience in multiple therapeutic and disease areas. Starting at the bench, Peter built his expertise by helping to drive projects from idea to clinically proven therapeutics. At Enveda, Peter is using this experience to help bring novel medicines from discovery to the clinic. In his spare time, Peter is a serial hobbyist, finding joy in chasing the hopes and dreams of family and friends.
Vice President Platform Chemistry
Marv has applied his expertise in synthetic chemistry across the drug discovery and development spectrum in both large pharma and biotech settings. At Enveda, he loves to find creative solutions to the challenges of drug discovery through the novel application of chemical technologies as evidenced by his publication and patent record. Playing bad golf, road cycling, and relaxing are his favorite past times.
Chief Medical Officer
Mark has had numerous leadership roles in academia, and the pharmaceutical biotech industries. He brings a passion for translational medicine and the desire to develop new medicines for patients to Enveda's growing clinical portfolio. Outside of work, Mark likes to read and run.
Vice President, Biology
Kendra has established a wide range of technology, target, modality, and therapeutic area experience during more than 20 years working in the pharmaceutical and life sciences. At Enveda, Kendra combines her foundation in the biological and chemical sciences, leadership experience, and passion for drug discovery to define and progress early discovery projects. In her free time, Kendra enjoys doing puzzles, traveling, and spending time with family.
Chief Technology Officer
Joe is a scientist, engineer, and entrepreneur. His passion for molecular biology, data science, and drug discovery helps drive innovation at Enveda. When he is not analyzing plant mass spectra, Joe is hiking or snowshoeing on the trails in Boulder with his family and his dog.
Vice President, Product
Hannah’s expertise encompasses disease biology and leveraging AI and ML technology to answer the right questions in drug discovery. Working with multiple cross-functional teams at Enveda, Hannah drives products to value inflection by deploying the right processes and infrastructure to balance the strengths across disciplines. Outside of her work at Enveda, Hannah enjoys spending time with her family, yoga, backcountry piloting, and exploring the beautiful mountains of Boulder.
Eswar Sunil Kumar Bonangi
Vice President, Head of India Operations
At Enveda, Eswar is responsible for scaling and integrating the company’s operations in India. He was responsible for the build-out of the company’s new facility in Hyderabad. Earlier, Eswar worked with KPMG as a Management Consultant and is experienced in strategy and operations. He is a passionate photographer and loves traveling.
Vice President, Data Science
David combines training in laboratory and computational biology with experience in data science and applied machine learning research. Before joining Enveda, he helped build the computational biology, computational chemistry, and machine learning research programs at Recursion Pharma. David loves sailing and fly fishing.
Chief of Staff
Dan oversees Enveda’s operations and leads its new initiatives. He is a trained molecular biologist. Prior to joining Enveda, he was the founder and CEO of a synthetic biology company, which was acquired in 2019. Outside of Enveda, Dan enjoys spending time in nature and traveling with his family.
Senior Vice President, Chemistry
Bryan joined Enveda after spending more than 25 years in big pharma drug discovery, where he led cross-functional discovery efforts, many of which culminated in clinical candidates for oncology, endocrine, and pain. At Enveda, Bryan heads up the lead generation chemistry group. Bryan enjoys photography, golf, traveling, and occasionally uses his chemistry know-how to brew beer.
Chief Platform Officer
August has a background in biomedical engineering with a degree from Rochester Institute of Technology. He was an early employee of Recursion Pharmaceuticals, where he helped scale their high-content imaging platform by multiple orders of magnitude before joining Enveda in 2021. At Enveda, he is responsible for overseeing the company’s efforts to further scale and maximize its proprietary drug discovery platform. When not building tools to automate drug discovery, August enjoys playing soccer and spending time with his dog.
Viswa is the founder and CEO of Enveda Biosciences. He has led the company through successful fundraising rounds and the scale-up of its discovery platform, which is based on metabolomics and machine learning, to unearth new medicines from its first-of-a-kind chemical map of the natural world. Before founding Enveda, Viswa led multiple drug development efforts at Recursion Pharmaceuticals. He earned his Ph.D. in immuno-oncology at the University of Wisconsin-Madison, where he developed candidate therapeutics for prostate cancer. Outside of work, Viswa loves playing racquet sports of all kinds and trying to read about a dozen books in parallel.
Senior Vice President | Discovery Chemistry
PK is an expert medicinal chemist and discovery scientist with proven leadership skills. He has delivered 18 clinical candidates, 12 of which were advanced to Phase I and six to Phase II clinical trials, while serving as Director of Medicinal Chemistry at DuPont Pharmaceuticals Co. and Senior Research Fellow at Eli Lilly & Co., among others. He looks forward to making contributions to Enveda’s natural products-based pipeline as Senior Vice President, Discovery Chemistry. In his free time, he enjoys hiking, traveling, and spending time with his family.
Pieter Dorrestein, Ph.D.
Scientific Co-Founder & SAB Chair | UC San Diego
Pieter is a leading metabolomics researcher and pioneer of groundbreaking mass spectrometry databases and tools. Pieter is also a Professor at the University of California – San Diego, where he serves as Director of the Collaborative Mass Spectrometry Innovation Center, and Co-Director at the Institute for Metabolomics Medicine.
We are proud to have elite industry, financial, and strategic expertise in our corner. From investors in iconic companies to architects of mega research and development deals, we are grateful for the opportunity to work with the best every day.
Yury Popov, Ph.D., M.D.
Associate Professor of Medicine, Division of Gastroenterology | Beth Israel Deaconess Medical Center
Richard Ulevitch, Ph.D.
Professor of Immunology, Chairman Emeritus of the Department of Immunology | The Scripps Research Institute
Ryan Shenvi, Ph.D.
Professor, Department of Chemistry - Professor, Department of Chemistry | The Scripps Research Institute
Ben Cravatt, Ph.D.
Professor, Department of Chemistry | The Scripps Research Institute
Pieter Dorrestein, Ph.D.
Scientific Co-Founder & SAB Chair | UC San Diego
Chris Gibson, Ph.D.
Founder & CEO | Recursion
Martin Brenner, Ph.D.
Former Executive Director, NASH | Merck & Co.
Kevin Lynch, Ph.D.
Former Vice President, Search & Evaluation | Abbvie
We’re proudly backed by some of the world’s leading investors that believe in the long-term, world-changing potential of our technologies.
We are proud to have elite industry, financial, and strategic expertise in our corner. From investors in iconic companies to architects of mega research and development deals, we are grateful for the opportunity to work with the best every day.Join the tribe